© 2021 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
© 2021 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
February 26, 2020
Utilizing the data of the CheckMate 9ER trial, researchers believe that combination therapies in the treatment of patients with renal cell carcinoma are the future of the landscape.
The Harshest Reality of Cancer You’ll Have to Face
Hope and Positivity May Help Lead to Recovery
Phase 1 Trial Begins for New Treatment Delivery Strategy in Pancreatic Cancer
Here's What Breast Cancer Survivors Had to Say About Staying Positive